510.20MMarket Cap-5492P/E (TTM)
7.470High6.730Low1.22MVolume6.830Open6.720Pre Close8.72MTurnover2.67%Turnover RatioLossP/E (Static)70.37MShares10.03052wk High2.33P/B330.03MFloat Cap3.26052wk Low--Dividend TTM45.52MShs Float28.360Historical High--Div YieldTTM11.01%Amplitude1.450Historical Low7.166Avg Price1Lot Size
Terns Pharmaceuticals Stock Forum
Larger Image: tradingview.com...
$Terns Pharmaceuticals (TERN.US)$
Terns Pharmaceuticals Highlights New Preclinical Data Supporting TERN-501 in Combination with a GLP-1R Agonist for Obesity at the ADA’s 84th Annual Scientific Sessions and Upcoming Conference Participation
Terns Pharmaceuticals announced new preclinical data supporting their compound TERN-501 in combination with a GLP-1 receptor agonist for treating obesity. The data was presented at the ADA’s 84th Annual Scientific Sessions. TERN-501, a highly selective THR-...
Larger Image: tradingview.com...
$Terns Pharmaceuticals (TERN.US)$
Larger Image: tradingview.com...
$Terns Pharmaceuticals (TERN.US)$
NEWS
Terns Pharmaceuticals Announces Data from Ongoing Phase 1 Pharmacokinetic Study of Allosteric BCR-ABL Inhibitor TERN-701 in Adult Healthy Volunteers and Highlights Potential for Competitive Differentiation
Larger Image: tradingview.com...
$Terns Pharmaceuticals (TERN.US)$
Larger Image: tradingview.com...
$Terns Pharmaceuticals (TERN.US)$
No comment yet